ATE171875T1 - Entzündungshemmender faktor, verfahren zur isolation und verwendung - Google Patents

Entzündungshemmender faktor, verfahren zur isolation und verwendung

Info

Publication number
ATE171875T1
ATE171875T1 AT91915601T AT91915601T ATE171875T1 AT E171875 T1 ATE171875 T1 AT E171875T1 AT 91915601 T AT91915601 T AT 91915601T AT 91915601 T AT91915601 T AT 91915601T AT E171875 T1 ATE171875 T1 AT E171875T1
Authority
AT
Austria
Prior art keywords
factor
milk
animal
inflammatory factor
isolation
Prior art date
Application number
AT91915601T
Other languages
English (en)
Inventor
Lee R Beck
Original Assignee
Stolle Res & Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Stolle Res & Dev filed Critical Stolle Res & Dev
Application granted granted Critical
Publication of ATE171875T1 publication Critical patent/ATE171875T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/20—Dietetic milk products not covered by groups A23C9/12 - A23C9/18
    • A—HUMAN NECESSITIES
    • A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
    • A24B15/00—Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
    • A24B15/18—Treatment of tobacco products or tobacco substitutes
    • A24B15/28—Treatment of tobacco products or tobacco substitutes by chemical substances
    • A24B15/30—Treatment of tobacco products or tobacco substitutes by chemical substances by organic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/20—Milk; Whey; Colostrum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/39508—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum from milk, i.e. lactoglobulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • A61K9/1647—Polyesters, e.g. poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/10—Immunoglobulins specific features characterized by their source of isolation or production
    • C07K2317/11—Immunoglobulins specific features characterized by their source of isolation or production isolated from eggs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Virology (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AT91915601T 1990-09-11 1991-06-12 Entzündungshemmender faktor, verfahren zur isolation und verwendung ATE171875T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/580,382 US5242691A (en) 1982-06-03 1990-09-11 Anti-inflammatory factor, method of isolation, and use

Publications (1)

Publication Number Publication Date
ATE171875T1 true ATE171875T1 (de) 1998-10-15

Family

ID=24320860

Family Applications (1)

Application Number Title Priority Date Filing Date
AT91915601T ATE171875T1 (de) 1990-09-11 1991-06-12 Entzündungshemmender faktor, verfahren zur isolation und verwendung

Country Status (13)

Country Link
US (1) US5242691A (de)
EP (1) EP0548123B1 (de)
JP (1) JPH08502718A (de)
AT (1) ATE171875T1 (de)
AU (1) AU660626B2 (de)
CA (1) CA2090011C (de)
DE (1) DE69130323T2 (de)
DK (1) DK0548123T3 (de)
ES (1) ES2124229T3 (de)
IE (1) IE912109A1 (de)
IL (1) IL98647A (de)
NZ (2) NZ238751A (de)
WO (1) WO1992004035A1 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5352462A (en) * 1982-06-03 1994-10-04 Stolle Research & Development Corporation Anti-inflammatory factor, method of isolation, and use
US5650175A (en) * 1982-06-03 1997-07-22 Stolle Research & Development Corporation Anti-inflammatory factor, method of isolation, and use
CA2086101C (en) * 1990-07-05 2002-11-19 Lee R. Beck Immune suppressive product from milk
US5747296A (en) * 1992-05-11 1998-05-05 Corvas International, Inc. Method of detecting neutophil inhibitory factor mimics
US6090380A (en) * 1994-01-12 2000-07-18 Research Corporation Technologies, Inc. Treatment of rheumatoid arthritis by oral administration of pooled human immunoglobulin
US5980953A (en) * 1994-10-03 1999-11-09 Stolle Milk Biologics, Inc. Anti-inflammatory factor, method of isolation, and use
DE19548221C1 (de) * 1995-12-22 1997-05-15 Biotest Pharma Gmbh Orale Anwendung von Immunglobulin-Präparationen zur Behandlung und Prophylaxe chronischer Schmerzzustände
CA2197515A1 (en) * 1996-07-15 1998-01-16 Reyad Mahmoud Methods of treating milk products
CA2264630C (en) 1996-09-06 2006-12-12 Pall Corporation Shear separation method and system
AUPP494798A0 (en) 1998-07-29 1998-08-20 Pacific Biolink Pty Limited Protective protein formulation
JP2001342127A (ja) * 2000-06-02 2001-12-11 Nomoto Kikuo 腸吸収性抗炎症因子含有免疫性物質及びその応用
CA2462682A1 (en) * 2001-10-04 2003-04-10 Protein Therapeutics, Inc. The use of gammaglobulin for the treatment of immune-mediated diseases
US6770280B1 (en) 2001-11-15 2004-08-03 Humanetics Corporation Treatment of menorrhagia, hypermenorrhea, dysmenorrhea and menstrual migraines by the administration of an antibacterial milk product
US20080026983A1 (en) * 2006-07-28 2008-01-31 Gardiner Paul T Compositions and methods for alleviating joint pain and improving joint flexibility
JP2011051914A (ja) * 2009-08-31 2011-03-17 Obihiro Univ Of Agriculture & Veterinary Medicine 低温殺菌処理ホエータンパク濃縮物を含む腸管炎症抑制剤

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3128230A (en) * 1961-04-04 1964-04-07 Sunbury Milk Products Co Milk having antibodies therein and process for producing same
US3376198A (en) * 1965-07-21 1968-04-02 Collins Products Inc Method of producing antibodies in milk
GB1211876A (en) * 1967-11-23 1970-11-11 Twyford Lab Ltd Improvements in and relating to prophylactic and therapeutic preparations
CH590064A5 (de) * 1973-11-28 1977-07-29 Biokema Sa
US4324782A (en) * 1974-01-28 1982-04-13 Beck Lee R Dental caries inhibiting product of immunized cow's milk having antibodies specific to killed Streptococcus mutans cells
US4732757A (en) * 1978-02-06 1988-03-22 Stolle Research And Development Corporation Prevention and treatment of rheumatoid arthritis
US4284623A (en) * 1979-11-09 1981-08-18 Beck Lee R Method of treating inflammation using bovine milk
ATE16349T1 (de) * 1981-04-28 1985-11-15 Stolle Res & Dev Verfahren zur herstellung einer entzuendungshemmenden rindermilch.
US4636384A (en) * 1982-06-03 1987-01-13 Stolle Research & Development Corporation Method for treating disorders of the vascular and pulmonary systems
US4897265A (en) * 1983-10-27 1990-01-30 Stolle Research & Development Corporation Method for treating disorders of the vascular and pulmonary systems
US4956349A (en) * 1983-10-27 1990-09-11 Stolle Research & Development Corporation Anti-inflammatory factor, method of isolation, and use
EP0300102B1 (de) * 1987-07-21 1993-03-24 The Stolle Research And Development Corporation Verfahren zum Erhalten von immunregulierenden Faktoren mittels Säugetierimmunisierung

Also Published As

Publication number Publication date
IL98647A0 (en) 1992-07-15
IL98647A (en) 1999-11-30
EP0548123A1 (de) 1993-06-30
IE912109A1 (en) 1992-03-11
NZ238751A (en) 1994-03-25
CA2090011A1 (en) 1992-03-12
DE69130323D1 (de) 1998-11-12
AU660626B2 (en) 1995-07-06
CA2090011C (en) 2003-12-30
ES2124229T3 (es) 1999-02-01
EP0548123B1 (de) 1998-10-07
DE69130323T2 (de) 1999-05-20
WO1992004035A1 (en) 1992-03-19
NZ250386A (en) 1997-06-24
DK0548123T3 (da) 1999-02-15
US5242691A (en) 1993-09-07
AU8434091A (en) 1992-03-30
JPH08502718A (ja) 1996-03-26
EP0548123A4 (en) 1993-12-08

Similar Documents

Publication Publication Date Title
ATE171875T1 (de) Entzündungshemmender faktor, verfahren zur isolation und verwendung
DE59003771D1 (de) Verfahren zur Herstellung von cyclischen Aminosäurederivaten sowie Zwischenprodukte.
ATE147366T1 (de) Verfahren zur herstellung von überzugfilmen aus titanoxyd
DE69214610D1 (de) Verfahren zur Behandlung von Erdgas
ATE174959T1 (de) Verfahren zur isolierung und kultivierung von transformierten zellen sowie verwendung dieser zellen zur herstellung individuumsspezifischer antikörper
DE3875575D1 (de) Verfahren und vorrichtung und vorrichtung zur herstellung und behandlung von transfermembranen.
DE59206237D1 (de) Strahlmittel, Verfahren zur Herstellung desselben sowie Verwendung des Strahlmittels
DE69321409D1 (de) Verfahren zur Ozonherstellung
DE59504792D1 (de) Verfahren zur Herstellung von Serienventilen
ATE141613T1 (de) Prozess zur darstellung von aspartam aus einem diketopiperazin sowie neue zwischenprodukte und derivate dafür
DE69207386D1 (de) Verfahren zur Herstellung hochintegrierter kontaktloser EPROM's
ATE375090T1 (de) Bioaktive peptide, ihre verwendung und verfahren zu ihre herstellung
DE69417115D1 (de) Verfahren zur Herstellung chirurgischen Nahtmaterials
DE69305763D1 (de) Verfahren zur Herstellung von metallischen Hydroxyden
DE69126477D1 (de) Verfahren zur Herstellung von Feldeffekttransistoren
DE69327515D1 (de) Verfahren zur Herstellung von überbasischen Phenolaten
ATA119593A (de) Verfahren zur behandlung von rohmilch durch homogenisierung und mikrofiltration
DE69314142D1 (de) Verfahren zur Herstellung von Keramikteilen
ATE108618T1 (de) Verfahren und vorrichtung zur herstellung von beta-kasein.
DE69607559D1 (de) Verfahren zur Behandlung von Phenolteer
ATE17007T1 (de) Neue o-alkyl-o-carbamoyl-glycero-phosphocholine und verfahren zu ihrer herstellung.
DE69116606D1 (de) Bacterin zur Behandlung von Necrophorum-Krankheiten und Verfahren zur Herstellung
DE59100212D1 (de) Verfahren zur verformenden behandlung von keratinfasern sowie mittel zur durchfuehrung des verfahrens.
DE68914660D1 (de) Verfahren zur Herstellung von den Safranblütennarben ähnlichem Gewebe sowie Verfahren zur Herstellung von nützlichen Stoffen aus safranblütennarbenähnlichem Gewebe.
DE69014042D1 (de) Verfahren zur Herstellung von menschlichem Osteocalcin.

Legal Events

Date Code Title Description
REN Ceased due to non-payment of the annual fee